Publications 2005
  1. García-González MA, Lanas A, Wu J, Benito R, Santolaria S, Crusius B, Peña S.
    Lack of association of IL-12 p40 gene polymorphism with peptic ulcer disease.
    Hum Immunol 2005;66, 72-76.
     
  2. Borm MEA, He J, Kelsall B, Peña AS, Strober W, Bouma G
    A major quantitative trait locus on mouse chromosome 3 is involved in disease susceptibility in different colitis models
    Gastroenterology 2005;128: 74-85.
  3. van der Paardt M, Crusius JBA, de Koning MH, Morré SA, van de Stadt RJ, Dijkmans BA, Peña AS, van der Horst-Bruinsma IE.
    No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitis.
    Ann Rheum Dis. 2005 Feb;64(2):235-8.
     
  4. Fidder HH, Chowers Y, Ackerman Z, Pollak RD, Crusius JBA, Livneh A, Bar-Meir S, Avidan B, Shinhar Y.
    The Familial Mediterranean Fever (MEVF) Gene as a modifier of Crohn's disease.
    Am J Gastroenterol 2005;100(2):338-343.
     
  5. Lyons JM, Ito JI, Peña AS, Morré SA.
    Differences in the growth characteristics and elementary body associated cytotoxin activity between Chlamydia trachomatis oculogenital serovars D and H and Chlamydia muridarum (MoPn).
    J Clin Pathol 2005;58(4):397-40.
     
  6. Ouburg S, Mallant-Hent R, Crusius JBA, van Bodegraven AA, Mulder CJJ, Linskens R, Peña AS, Morré SA.
    The Toll-like receptor 4 (TLR4) Asp299Gly polymorphism is associated with colonic localization of Crohn’s disease, without a major role for the Saccharomyces cerevisiae mannan-LBP-CD14-TLR4 pathway.
    Gut 2005;54(3):439-40.
     
  7. Van der Linde K, Boor PPC, van Bodegraven AA,de Jong DJ, Crusius JBA, Naber THJ, Kuipers EJ, Wilson JHP, de Rooij FWM.
    A functional interleukin-10 mutation in Dutch patients with Crohn's disease
    Dig Liver Dis 2005;37(5):330-5.
     
  8. Lyons JM, Ito JI, Morré SA.
    The influence of vaginally applied imiquimod on the course of Chlamydia trachomatis serovar D in a murine model of genital tract infection.
    Infect Dis Obstet Gynecol 2005;13(1): 1-3
     
  9. van der Paardt M, Crusius JBA, Garcia-Gonzalez MA, Dijkmans BAC, Peña AS, van der Horst-Bruinsma IE.
    Susceptibility to ankylosing spondylitis: no evidence for the involvement of transforming growth factor beta 1 (TGFB1) gene polymorphisms.
    Ann Rheum Dis 2005;64(4):616-9.
     
  10. Guo QS, Xia B, Jiang Y, Morré SA, Cheng L, Li J, Crusius JBA, Peña AS.
    Polymorphisms of CD14 gene and TLR4 gene are not associated with ulcerative colitis in Chinese patients.
    Postgrad Med J 2005;81(958):526-9.
     
  11. Shang J, Peña AS. Multidisciplinary approach to understand the pathogenesis of gastric cancer.
    World J Gastroenterol 2005;11:4131-9.
     
  12. Spaargaren J, Fennema HSA, Morré SA, de Vries HJC, Coutinho RA.
    New lymphogranuloma venereum Chlamydia trachomatis variant, Amsterdam.
    Emerging Infect Dis 2005:11(7):1090-2.
     
  13. Pannekoek Y, Spaargaren J, Langerak A, Merks J, Morré SA, van der Ende A.
    Interrelationship between polymorphism of incA, fusogenic properties of Chlamydia trachomatis strains and clinical manifestations in patients in the Netherlands.
    J Clin Microbiol 2005;43:2441-3.
     
  14. Garcia-Gonzalez MA, Savelkoul PHM, Benito R, Santolaria S, Crusius JBA, Peña AS , Lanas A
    No allelic variant associations of the IL-1 and TNF gene polymorphisms in the susceptibility to duodenal ulcer disease
    Int. J Immunogen2005; 32:299-306
  15. Eich HP, de la Calle G, Diaz C, Boyer S, Pena AS, Loos BG, Ghazal P, Bernstein I.
    Practical Approaches to the Development of Biomedical Informatics: the INFOBIOMED Network of Excellence.
    Stud Health Technol Inform 2005;116:39-44.
  16. Barr EL, Ouburg S, Igietseme JU, Morre SA, Okwandu E, Eko FO, Ifere G, Belay T, He Q, Lyn D, Nwankwo G, Lillard J, Black CM, Ananaba GA.
    Host inflammatory response and development of complications of Chlamydia trachomatis genital infection in CCR5-deficient mice and subfertile women with the CCR5delta32 gene deletion.
    J Microbiol Immunol Infect 2005;38:244-54.
  17. Moreno ML, Crusius JBA, Cherñavsky A, Sugai E, Sambuelli A, Vazquez H, Mauriño E, Peña AS, Bai JC.
    The IL-1 gene family and bone involvement in celiac disease.
    Immunogenetics 2005; 87(8): 618-20
  18. Morré SA, Spaargaren J, Fennema JSA, de Vries HJC, Peña AS.
    Real-time polymerase chain reaction to diagnose Lymphogranuloma Venereum
    Emerg Infect Dis 2005;11(8):1311-12.
     
  19. Laine ML, Morré SA, Murillo LS, van Winkelhoff A-J, Peña AS.
    CD14 and TLR4 gene polymorphisms in adult periodontitis
    J Dental Res 2005, 84(11):1042-1046.
     
  20. Karimi O, Peña AS, van Bodegraven AA.
    Probiotics (VSL#3) in Arthralgia in Patients with Ulcerative Colitis and Crohn’s Disease. A Pilot Study
    Drugs Today (Barc). 2005;41(7):453-9.
  21. Karimi O and Peña AS.
    Probiotics in arthralgia and spondyloarthropathies in patients with inflammatory bowel disease. Prospective randomized trials are necessary.
    Rev Esp Enf Dig 2005;97(8):570-574
  22. Barreiro M, Núñez C, Domínguez-Muñoz JE, Lorenzo A, Barreiro F, Potel J, Peña AS.
    Association between NOD2/CARD15 mutations with previous surgical procedures in Crohn’s disease.
    Rev Esp Enf Diges (Madrid) 2005; 97: 97(8)547-53
  23. Ouburg S, Crusius JBA, Klinkenberg-Knol EC, Mulder CJJ, Peña AS, Morré SA.
    A candidate gene approach of immune mediators affecting the susceptibility to and severity of upper gastrointestinal tract diseases in relation to Helicobacter pylori and Epstein-Barr virus infections.
    Eur J Gastroenterol Hepatol. 2005; 17:1212-24.
     
  24. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, Caprilli R, Colombel JF, Gasche C, Geboes K, Jewell DP, Karban A, Loftus Jr EV, Peña AS, Riddell RH, Sachar DB, Schreiber S, Steinhart AH, Targan SR, Vermeire S, Warren BF.
    Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.
    Can J Gastroenterol 2005;19 Suppl A:5-36.
  25. Cox DG, Crusius JB, Peeters PH, Bueno-de-Mesquita HB, Pena AS, Canzian F.
    A haplotype of prostaglandin synthase 2/cyclooxygenase 2 is involved in the susceptibility to inflammatory bowel disease.
    World J Gastroenterol 2005;11:6003-8.
  26. Lyons JM, Morré SA, Airo-Brown LP, Peña AS, Ito JI Jr.
    Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice.
    J Microbiol Immunol Infect 2005; 38(6):383-93.
  27. Spaargaren J, Schachter J, Moncado J, Fennema HSA, de Vries HJC, Coutinho RA, Morré SA.
    Slow Epidemic of Lymphogranuloma Venereum L2b Strain.
    Emerging Infect Dis 2005; 11(11):1787-8.
  28. Lammers KM, Ouburg S, Morré SA, Crusius JBA, Gionchetti P, Rizzello F, Morselli C, Caramelli E, Conte R, Poggioli G, Campieri M, Peña AS.
    Combined carriership of TLR9 –1237C and CD14 –260T alleles enhances the risk of developing chronic relapsing pouchitis
    World Journal of Gastroenterology 2005; 11(46):7323-9.
  29. Vanrompay D, Hoang TQT, De Vos L, Verminnen K, Chiers K, Morré SA, Cox E.
    Specific pathogen free pigs as an animal model for studying Chlamydia trachomatis genital infection
    Infection and Immunity 2005; 73(12):8317-21.
  30. Lyons JM, Morré SA, Airo-Brown LP, Peña AS, Ito JI.
    Acquired homotypic and heterotypic immunity against oculogenital Chlamydia trachomatis serovars following female genital tract infection in mice.
    BMC Infectious Diseases 2005; 5(1):105.
     
  31. Ouburg S, Spaargaren J, den Hartog JE, Land JA, Fennema JS, Pleijster J, Peña AS, Morré SA.

    The CD14 functional gene polymorphism -260 C>T is not involved in either the susceptibility to Chlamydia trachomatis infection or the development of tubal pathology.

    BMC Infect Dis. 2005;5:114.